UCB SA
UCB.BR
Price:
$189.4
Market Cap:
$35.93B
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treati...[Read more]
Industry
Biotechnology
IPO Date
2000-01-04
Stock Exchange
EURONEXT
Ticker
UCB.BR
PE Ratio
[156.53]
ROE
[2.68%]
Current Ratio
[1.19]
Dividend Yield
[0.72%]
Enterprise Value
[38.54B]
Dividend History
UCB.BR Dividend History Overview
Dividends are a key part of long-term returns for investors, and UCB SA (UCB.BR) has a track record worth reviewing. Looking at dividend history for UCB.BR gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2024-04-26
Dividend Yield
0.72%
Annual Dividend
$1.36
P/E Ratio
156.53
Payout Ratio
1.08
Dividend per Share
$1.36
EPS
1.21
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2024-04-26 | $1.36 | $1.36 | 2024-04-30 | |
| 2023-04-28 | $1.33 | $1.33 | 2023-05-03 | |
| 2022-04-29 | $1.3 | $1.3 | 2022-05-03 | |
| 2021-04-30 | $1.27 | $1.27 | 2021-05-04 | |
| 2020-05-04 | $1.24 | $1.24 | 2020-05-06 | 2020-04-29 |
| 2019-04-26 | $1.21 | $1.21 | 2019-04-30 | 2019-02-28 |
| 2018-04-27 | $1.18 | $1.18 | 2018-05-02 | 2018-02-22 |
| 2017-04-28 | $1.15 | $1.15 | 2017-05-03 | 2017-02-23 |
| 2016-04-29 | $1.1 | $1.1 | 2016-05-03 | 2016-02-29 |
| 2015-05-04 | $1.06 | $1.06 | 2015-05-06 | 2015-03-02 |
| 2014-04-29 | $1.04 | $1.04 | 2014-05-05 | 2014-03-03 |
UCB SA (UCB.BR) Dividend History Chart
The table below shows UCB SA (UCB.BR) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
UCB SA (UCB.BR) Dividend Growth
UCB SA (UCB.BR) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Solvay SA (SOLB.BR) | 0.08% |
| KBC Group NV (KBC.BR) | 0.06% |
| Groupe Bruxelles Lambert SA (GBLB.BR) | 0.03% |
| ageas SA/NV (AGS.BR) | 0.07% |
| Ackermans & Van Haaren NV (ACKB.BR) | 0.02% |
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like UCB SA (UCB.BR) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is UCB.BR’s dividend yield?
What is the difference between regular and special dividends?
Has UCB.BR increased its dividends over time?
Why might dividend history data be delayed?
How often does UCB.BR pay dividends?
What factors impact UCB.BR's dividend payments?
Can dividends change over time?
What is UCB.BR’s next dividend date?